title: Amyotrophic lateral sclerosis prognosis, Alzheimer's disease and end-of-life care, anxiety and cancer, cirrhosis as a terminal illness.
abstract: This feature is based on actual questions and answers received and responded to by the Hospice Foundation of America (HFA). This is a service provided for families and support group members of patients with advanced disease by William M. Lamers, MD, HFA Medical Consultant a member of this Journal's Editorial Board. In this issue, queries and responses are presented addressing the prognosis for a patient with amyotrophic lateral sclerosis, end-of-life care for a patient with advanced Alzheimer's disease, anxiety in cancer and cirrhosis as a life ending disease.
authors.affiliation: Lamers Medical Group, 9515 Seabreeze Terrace, Malibu, CA, 90265-2223, USA. lamers@earthlink.net
authors.forename: William M
authors.initials: WM
authors.lastname: Lamers
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis* / Q000503:physiopathology; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology*; D001943:Breast Neoplasms / Q000150:complications*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis* / Q000503:physiopathology; D011379:Prognosis; D013727:Terminal Care / Q000379:methods*
chemical_list: D014151:Anti-Anxiety Agents